SI
GHDX

Scout Investments’s Genomic Health, Inc. GHDX Stock Holding History

Scout Investments’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-109,268
Closed -$6.36M – 296
2019
Q2 		$6.36M Buy
109,268
+43,375
+66% +$2.57M 0.12% 184
2019
Q1 		$4.62M Sell
65,893
-2,119
-3% -$157K 0.09% 183
2018
Q4 		$4.38M Sell
68,012
-12,385
-15% -$868K 0.11% 175
2018
Q3 		$5.64M Buy
80,397
+1,700
+2% +$99.4K 0.12% 192
2018
Q2 		$3.97M Sell
78,697
-803
-1% -$31.9K 0.09% 200
2018
Q1 		$2.49M Buy
79,500
+6,050
+8% +$201K 0.06% 266
2017
Q4 		$2.51M Buy
73,450
+400
+0.5% +$12.8K 0.06% 258
2017
Q3 		$2.34M Sell
73,050
-25
-0% -$788 0.06% 251
2017
Q2 		$2.38M Buy
73,075
+2,775
+4% +$87.9K 0.07% 239
2017
Q1 		$2.21M Buy
70,300
+150
+0.2% +$4.44K 0.06% 239
2016
Q4 		$2.06M Hold
70,150
– – 0.06% 236
2016
Q3 		$2.03M Hold
70,150
– – 0.06% 233
2016
Q2 		$1.82M Hold
70,150
– – 0.05% 229
2016
Q1 		$1.74M Buy
70,150
+350
+0.5% +$9.61K 0.05% 230
2015
Q4 		$2.46M Sell
69,800
-4,400
-6% -$118K 0.06% 206
2015
Q3 		$1.57M Hold
74,200
– – 0.04% 223
2015
Q2 		$2.06M Hold
74,200
– – 0.04% 224
2015
Q1 		$2.27M Hold
74,200
– – 0.04% 225
2014
Q4 		$2.37M Buy
74,200
+350
+0.5% +$11.4K 0.04% 211
2014
Q3 		$2.09M Hold
73,850
– – 0.03% 214
2014
Q2 		$2.02M Buy
73,850
+375
+0.5% +$9.98K 0.02% 213
2014
Q1 		$1.94M Hold
73,475
– – 0.02% 224
2013
Q4 		$2.15M Buy
73,475
+125
+0.2% +$3.97K 0.02% 230
2013
Q3 		$2.24M Buy
73,350
+8,600
+13% +$288K 0.02% 303
2013
Q2 		$2.05M Buy
+64,750
New +$2.13M 0.02% 216

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Scout Investments's GHDX Position: Q3 2019 in Review

Scout Investments sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 109,268 shares — an estimated $6.36M sold.

Scout Investments first reported a position in GHDX in Q2 2013 and held it in 25 quarters. The position peaked at $6.36M in Q2 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Scout Investments reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Scout Investments sold 109,268 Genomic Health, Inc. shares in Q3 2019, an estimated $6.36M.
  • Scout Investments first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 25 quarters.
  • Scout Investments's Genomic Health, Inc. position peaked at $6.36M in Q2 2019.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Scout Investments's 13F filing for Q3 2019, filed 8 Oct 2019.